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Acute-onset obsessive-compulsive disorder can be challenging, especially when triggered by an underlying disease process.
Clinicians often turn to Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections
(PANDAS), but it is important to consider a broad differential in these patients. We present a case of a 9-year-old girl with
acute-onset obsessive-compulsive behavior likely triggered by a post-infectious phenomenon that ultimately resolved following
treatment with plasmapheresis.
1. Introduction
Obsessive-compulsive disorder (OCD) is a debilitating disease
characterized by repetitive, ritualistic, and distressing thoughts
and behavior which can be very difficult to control. It affects
about 1-3% of school-aged children and adolescents [1, 2].
The cause of obsessive-compulsive disorder is unknown; how-
ever, a combination of genetic and environmental factors may
be contributory [3]. In a subset of patients, underlying disease
processes such as infectious, postinfectious, and autoimmune
phenomena can trigger OCD [4]. We report a 9-year-old girl
with no significant past medical history who presented to the
emergency department (ED) with acute-onset obsessive-
compulsive behavior in the setting of positive anti-glutamic
acid decarboxylase 65 (anti-GAD 65) and Mycoplasma pneu-
moniae antibodies. Here, we discuss her symptoms, diagnostic
evaluation, and the treatment she received.
2. Case Presentation
Our patient was a 9-year-old previously healthy girl who pre-
sented to the ED with a chief complaint of acute-onset
obsessive-compulsive behavior. Eleven days prior to presen-
tation, she became emotionally labile, manifested as sudden
episodes of sadness, withdrawal, and unwillingness to partic-
ipate in social events. Five days prior to admission, her par-
ents observed her displaying ritualistic behaviors such as
watching a YouTube commercial 75 times, walking in certain
patterns, taking her pajamas on and off a certain amount of
times before going to school, picking her lips, and banging
her ankles and the side of her abdomen against the kitchen
counter. These behaviors would occupy the patient for 4-6
hours, affecting her ability to function normally. She
explained that if she did not engage in these behaviors, she
would continue to think about them and was worried that
something bad may happen to her or her parents. She was
also described as having decreased concentration and diffi-
culty performing simple mathematical equations. This was
very unusual, as her parents described her as a highly spirited
and functional child who is popular at school—participating
in advanced math classes, piano, tennis, and gymnastics.
Concerned with her behavior, she was taken to her pri-
mary doctor whose workup included Epstein-Barr virus
(EBV) serology, anti-deoxyribonuclease (anti-DNase),
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antistreptolysin O (ASO), thyroid function tests (TFTs),
complete blood count (CBC), comprehensive metabolic
panel (CMP), thyroid-stimulating hormone/thyroxine
(TSH/T4), and Lyme serology (all within normal limits).
An impression of PANDAS was made, and she went home
on amoxicillin and fluoxetine, which she took for two days
prior to her presentation to our ED.
The family considered stress as a possible contributing
factor and spent a weekend away from home for a change
in environment. In their hotel room, she would ritualize
walking back and forth several times. If she failed to complete
these rituals, it would result in emotional outbursts and a
strong urge to repeat them. Her ability to eat and drink was
also impaired, causing her to become dehydrated and
prompting her parents to bring her to the ED. This process
took five hours due to her extreme reluctance to leave the
hotel room before completing her rituals.
Review of systems was significant for the following: con-
stitutional—negative for malaise and weight loss; skin—ne-
gative for rash, positive for bruising on ankles and waist;
gastrointestinal—negative for vomiting and abdominal pain;
neurologic—negative for weakness, neck pain, neck stiffness,
paresthesia, and seizures.
Family history was significant for anxiety in both parents.
Socially, she was living with her parents with strong support
from her grandparents who live nearby. No report of sexual
abuse, physical abuse, or bullying at school. Her medications
included fluoxetine and amoxicillin that were started two
days prior to hospitalization by her pediatrician. Allergies
included oseltamivir.
On examination, she appeared well looking, in no appar-
ent distress. Her vitals were normal; central nervous system
(CNS)—neck supple, pupils equal and round, reactive to
light (PEARRL), cranial nerves II-XII intact, motor, sensa-
tion, and power normal; Her affect was normal, and her
mood was congruent; Head, eyes, ears, nose, and throat
(HEENT)—mucous membranes dry; skin—healing bruises
on her ankles and waist; cardiovascular, respiratory, and
abdominal exams were normal.
In the ED, she received maintenance intravenous fluids
(IVF) and was admitted to the general pediatrics floor with
a presumptive diagnosis of Pediatric Acute-onset Neuropsy-
chiatric Syndrome (PANS).
She continued to perform rituals in the hospital, request-
ing the participation of her parents to suppress them. When
moving objects in the room, they would need to carry them
over her in a certain way several times to complete the ritual
without upsetting her. As her admission progressed, her
urges became overwhelming, and she ultimately returned to
performing the rituals herself. She paced several times across
the hospital, resisting the urge to urinate until she had com-
pleted the task. This resulted in episodes of pain and distress
attributed to acute urinary retention that resolved with void-
ing. She also regressed developmentally, showing more inter-
est in cartoons targeted for younger children, and continued
to refuse to drink, requiring IVF intermittently.
2.1. Diagnostic Evaluation. Psychiatry, psychology, and neu-
rology services were consulted to help guide the patient's
evaluation and treatment. She underwent a series of tests to
identify a secondary cause of her presentation. This included
a CBC [mild microcytic anemia], CMP [normal], Lyme
serology [normal], brain magnetic resonance imaging
(MRI) [mild prominence of sulci likely secondary to dehy-
dration], repeat brain MRI about 3 weeks from the first [nor-
mal], lumbar puncture (LP) with opening pressure [normal],
cerebrospinal fluid (CSF) microscopy and chemistry [nor-
mal], CSF autoimmune profile [normal], electroencephalo-
gram (EEG) [normal], serum autoimmune encephalopathy
panel [positive for anti-GAD 65 at 0.05, resulted day 16],
serum N-methyl D-aspartate (NMDA) antibodies [nega-
tive], and M. pneumoniae serum antibodies [IgG and
IgM positive, resulted day 3] with confirmatory M. pneu-
moniae IgM indirect immunofluorescence assay (IFA)
[positive, resulted day 3].
2.2. Therapeutic Interventions. Amongst the consulting ser-
vices, there were varying opinions regarding the diagnosis
and treatment of the patient. Psychiatry cited case reports
and experiences with patients withM. pneumoniae infections
associated with OCD that responded to azithromycin. At
their recommendation, azithromycin was initiated for a 30-
day course. However, this was discontinued on day 13
because she developed diarrhea in the setting of underlying
dehydration, in addition to a lack of clinical improvement.
At this time, psychotropic medications were not started so
as not to confound the possible response to azithromycin.
Psychology attempted a reward system to encourage oral
(PO) intake, but she continued to intermittently require IVF
due to inadequate intake as a result of interference from her
rituals.
On day 9 of hospitalization, psychiatry recommended
starting intravenous methylprednisolone (1.5mg/kg/dose),
however, no clinical response was observed after a 5-day
course. Lorazepam was initiated as needed for agitation and
ritual control at this time.
Due to the lack of response to the above treatments
(azithromycin, reward system, steroids), intravenous
immunoglobulin (IVIG) was considered, however not ini-
tiated due to a national shortage. The ultimate decision
to attempt plasmapheresis was made on day 16 of hospi-
talization when the anti-GAD 65 was found to be posi-
tive. After her first session of plasmapheresis, she
showed some improvement— she was able to participate
in Halloween activities (trick-or-treat), and her rituals
were less repetitive with an improvement in her PO
intake. She received a total of five rounds of plasmaphe-
resis before her compulsions decreased significantly. Ser-
traline 10mg daily was initiated on day 23 of
hospitalization. She was ultimately discharged after about
one month of inpatient care, and continued to follow up
with her outpatient psychologist, psychiatrist, and pedia-
trician. Her outpatient psychiatrist increased her sertra-
line dosage to 15mg and added Vitamin D 1000-
2000 units daily. She also completed an outpatient inten-
sive behavioral health program after her discharge.
Within a few weeks of her discharge, her compulsions
and intrusive thoughts had dissipated completely.
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3. Discussion
Our patient was positive for Mycoplasma pneumoniae IgM
and IgG in the setting of a recent upper respiratory infection
(URI), suggesting an antecedent M. pneumoniae infection.
The medical literature describes case reports of the associa-
tion ofM. pneumoniaewith acute-onset OCD and other neu-
ropsychiatric disorders [5, 6]. She was also positive for anti-
GAD 65 antibodies, which are reportedly associated with
reduced gamma-aminobutyric acid (GABA) transmission
and can lead to seizures, increased anxiety, behavioral
changes, and encephalitis [7]. However, anti-GAD 65
levels> 20 have a higher positive predictive value for enceph-
alitis, and her level of 0.05 is unlikely to be clinically signifi-
cant [8].
She did not respond to azithromycin despite receiving a
13-day course. We hypothesize that she did not have an
active M. pneumoniae infection on presentation, rendering
the antibiotics ineffective, but may have experienced a post-
infectious process in the form of M. pneumoniae-induced
antineuronal antibodies.
She also received steroids with minimal effect. Steroids
are estimated to reduce antibody production by 10-20 per-
cent [9], which may not be an adequate nadir to produce a
clinical response. However, the dramatic response to plasma-
pheresis suggests that the inciting antibodies were ultimately
cleared and no longer exerting their antineuronal effect.
Whether this improvement was secondary to clearance of
M. pneumoniae-associated antibodies or anti-GAD 65 anti-
bodies remains unclear.
Our patient's initial diagnosis was PANDAS/PANS
which is a controversial diagnosis with conflicting evidence
in the medical literature. The diagnostic criteria for PANDAS
were first proposed in 1998 [4], and further revised as PANS
in 2012 to include patients without group A streptococcal
(GAS) infection [10], but are beyond the scope of this
discussion.
Some authors have proposed steering away from PAN-
DAS/PANS and coining childhood acute-onset neuropsychi-
atric syndrome (CANS) as an umbrella term with a strong
emphasis on identifying the underlying etiology [11]. Using
this approach, the differential diagnosis for any child present-
ing with neuropsychiatric symptoms includes infections,
postinfectious sequelae, autoimmune disease, drug-induced,
metabolic, traumatic, primary psychiatric disorder, and idio-
pathic, which we have listed as a guide to clinicians (Table 1).
A list of investigations has been proposed to guide clini-
cians (Table 2) [11]; however, no consensus has been docu-
mented. Clinicians should therefore obtain a thorough
history and physical examination in order to formulate a
comprehensive differential diagnosis, appropriate investiga-
tions, and a management plan. In patients with severe symp-
toms such as ours, an extensive evaluation is warranted.
Limitations of our evaluation included the lack of throat
culture for GAS, which was arguably appropriate as the
patient had no URI symptoms. More importantly, an ANA
was not performed, which is commonly overlooked. This is
an important test to consider as childhood-onset SLE can
present with neuropsychiatric symptoms in two-thirds of
patients [12].
For treatment, antibiotics should be used only when an
active infection has been documented, for example,M. pneu-
moniae. Prolonged antibiotic use increases the risk of adverse
drug reactions, as in this case, and antimicrobial resistance.
Table 1: Differential diagnosis for CANS.




































Table 2: List of suggested investigations for CANS.
Blood CSF Brain imaging
CBC, CMP, ammonia, erythrocyte sedimentation
rate (ESR), C-reactive protein (CRP), ASO, anti-DNAse B,
TSH, T4, anti-thyroglobulin, anti-thyroperoxidase, urine drug
screen (UDS), ethanol level, acetaminophen and
salicylate levels, antinuclear antibodies (ANA), autoimmune
encephalitis panel
Cell count, differential, glucose, protein, gram
stain, bacterial and viral polymerase chain
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The use of steroids, IVIG, and plasmapheresis should be
determined on a case-by-case basis, strongly evaluating the
risk-to-benefit ratio for each modality. Institutions are
encouraged to develop clinical pathways and multidisciplin-
ary teammeetings to ensure appropriate use of the aforemen-
tioned modalities. Cognitive-behavioral therapy (CBT) and
selective serotonin reuptake inhibitors (SSRIs) are reasonable
adjuncts as the risk of harm is low.
Our patient underwent an extensive and invasive diag-
nostic workup, several unsuccessful treatments, and spent
nearly an entire month admitted to the hospital before her
symptoms improved. This is a severely debilitating condition
that requires more high-quality research to fully understand
its pathophysiology and evaluate the efficacy of various
treatment options.
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